Mebehope 200 XR contains Mebeverine 200 mg, an antispasmodic agent primarily used to alleviate symptoms associated with irritable bowel syndrome (IBS) and other functional gastrointestinal disorders. Mebeverine acts directly on the smooth muscle of the gastrointestinal tract, exerting a relaxing effect that helps reduce muscle spasms and cramps without affecting normal gut motility. This extended-release formulation ensures a sustained therapeutic effect, improving patient compliance by allowing less frequent dosing. Mebehope 200 XR is indicated for the relief of abdominal pain, discomfort, bloating, and altered bowel habits commonly experienced in IBS. It is well-tolerated, with a low incidence of adverse effects, which may include mild gastrointestinal disturbances or allergic reactions in rare cases. The medication should be used under medical supervision, especially in patients with known hypersensitivity to Mebeverine or any excipients. It is contraindicated in individuals with mechanical obstruction of the gastrointestinal tract or severe liver impairment. Dosage adjustments may be necessary based on clinical response and patient tolerance. Mebehope 200 XR offers an effective therapeutic option for managing functional bowel disorders, enhancing quality of life through symptom control and improved gastrointestinal comfort.